ALKERMES | Rörelsekostnader



Operating Expenses Ändra Datum
AbbVie USD 9.61B 6.98B 2025-03
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
ALKERMES USD 267.3M 6.09M 2024-12
Amgen USD 6.78B 401M 2024-12
Biogen USD 2.01B 13.3M 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
J&J USD 8.26B 10.37B 2025-03
Malin Corporation EUR 700K 1.6M 2024-06
Merck USD 9.66B 1.67B 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Otsuka Holdings JPY 458.42B 78.85B 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



ALKERMES Rörelsekostnader - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.